InsidersTradesSigma
Follow the Immune Design Corp. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €222.9m. The latest transaction was filed on 6 January 2016 (Attribution). Among the most active insiders: Brady Stephen R. All data is accessible without an account.
Analysts rate Immune Design Corp. Strong Buy (bullish), based on 4 analysts. Average price target: US$8.61.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Immune Design Corp. 是一家生物制药公司，专注于开发癌症和传染病的免疫疗法。该公司在纳斯达克上市，股票代码为 IMDZ。